Markets / 992b4011...

Will the new mRNA vaccine for pancreatic cancer show statistically significant survival benefits by June 2026?

Price50¢/share

Fee1¢

You spend10¢

If correct19¢ (+9¢)

About this market

This market resolves to Yes if, by June 30, 2026, there is a published study or clinical trial results indicating that the new mRNA vaccine for pancreatic cancer provides statistically significant survival benefits compared to existing treatments.

Rules

Market closes at 6/30/2026.
Logic weighted resolution applies.

Will the new mRNA vaccine for pancreatic cancer show statistically significant survival benefits by June 2026?

Will the new mRNA vaccine for pancreatic cancer show statistically significant survival benefits by June 2026?

About this market

Rules

Will the British National Formulary for Children be integrated into all NHS electronic systems by June 30, 2026?

Will the MV Hondius dock at the Canary Islands without further hantavirus cases by May 31, 2026?

Will the Abridge AI Platform reach 500 health system partners by June 30, 2026?

Will Wake County Commissioners delay the vote on WakeMed and Atrium merger past June 30, 2026?

Will the merger between WakeMed and Atrium Health be approved by June 30, 2026?

Will any GLP-1 drug warning related to osteoporosis be issued by June 30, 2026?